News
GARDASIL 9 is a vaccine that helps protect against disease caused by the following types of Human Papillomavirus (HPV): 6, 11, 16, 18, 31, 33, 45, 52 and 58. For more information, see Section 1.
Hosted on MSN19d
Drugmaker Merck opens state-of-art $1B facility to manufacture HPV Gardasil, other vaccinesThe $1 billion plant will manufacture the HPV vaccines Gardasil and Gardasil 9, while the site continues to produce vaccines against measles, mumps, rubella, and chickenpox, among other illnesses ...
MSD's Gardasil®9, a nine-valent HPV vaccine, is approved for use in males between 16 and 26 years old by China's National Medical Products Administration on Monday. [Photo provided to chinadaily ...
United States-based global pharmaceutical company MSD said on Monday that China's National Medical Products Administration has approved the use of multiple new indications of Gardasil®9, its ...
Because Gardasil is not part of China’s national immunisation programme, consumers must pay out of pocket to receive the vaccine. GSK has also felt the impact. In December 2024, GSK’s Chinese ...
The Union Health Ministry is planning to roll out capacity-building activities for frontline workers involved in the administration of Human Papillomavirus (HPV) vaccination, sources said.
Kennedy Jr., experts looked poised to change policies around vaccines that defend against two of the world’s most high-profile viruses—COVID and HPV. Following Tuesday's deliberations ...
With revenue in 2024 estimated at USD 17.0 billion, the sector is experiencing an accelerated demand due to the expansion of vaccine development, temperature-sensitive biologics, and stringent ...
MRK’s leading HPV vaccine, GARDASIL 9, faced challenges internationally due to inventory buildup within its Chinese distributor, which is expected to reduce shipments for the remainder of 2024.
The global tablets and capsules packaging market is poised for significant growth over the next decade. The market size, estimated to be worth USD 5.3 billion in 2025, is expected to reach USD 9.0 ...
This vaccine showed 100% protection in mice studies against a lethal H5N1 bird flu strain. This week the results were published in a peer-reviewed scientific journal. RELATED: More bird flu ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results